Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 257 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q2
YC CONSULTING, LLC for PATIENTS RISING NOW
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues
View →
Q2
ALLIANCE FOR REGENERATIVE MEDICINE for ALLIANCE FOR REGENERATIVE MEDICINE
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q2
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q2
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q2
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Taxation/Internal Revenue Code
View →
Q2
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues
View →
Q2
SPLITOAK STRATEGIES LLC for CHIESI USA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · North Carolina · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Agriculture
View →
Q2
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Agriculture, Animals, Budget/Appropriations
View →
Q2
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
AVENUE SOLUTIONS for ALLIANCE FOR REGENERATIVE MEDICINE
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q2
ALSTON & BIRD LLP for ST. JUDE CHILDREN'S RESEARCH HOSPITAL
2nd Quarter (Apr 1 - June 30) 2025 · Tennessee · House · Senate · $10,000.00 income
Health Issues
View →
Q2
AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q2
MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
2T
SPARK THERAPEUTICS, INC. for SPARK THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate
Medicare/Medicaid, Health Issues
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code, Tobacco, Budget/Appropriations
View →
Q2
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
INCYTE CORPORATION for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate
Medicare/Medicaid
View →
Q2
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid
View →
Q2
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Taxation/Internal Revenue Code, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate
Pharmacy
View →
Q2
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $80,000.00 income
Health Issues, Taxation/Internal Revenue Code
View →
Previous Page 8 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem